Ignite Creation Date:
2024-05-06 @ 1:21 AM
Last Modification Date:
2024-10-26 @ 11:02 AM
Study NCT ID:
NCT01782872
Status:
COMPLETED
Last Update Posted:
2016-05-18
First Post:
2012-09-24
Brief Title:
Analgesia After Total Shoulder Arthroplasty
Sponsor:
Hospital for Special Surgery New York
Organization:
Hospital for Special Surgery New York
Study Overview
Official Title:
Analgesia After Total Shoulder Arthroplasty
Status:
COMPLETED
Status Verified Date:
2016-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine which medications should be included in the interscalene nerve block an injection of local anesthetic numbing medicine near nerves in the shoulder for patients undergoing total shoulder arthroplasty shoulder replacement The ideal nerve block would reduce pain after shoulder surgery without causing a great deal of muscle weakness
Detailed Description:
All patients will receive an intravenous pain pump patient-controlled analgesia and a nerve block with long-lasting local anesthetic The three study groups will receive additives clonidine dexamethasone buprenorphine plus local anesthetic in the nerve block that may reduce postoperative pain One of the study groups uses the usual concentration of local anesthetic while the other two study groups use reduced concentrations of local anesthetic Follow-up with study patients begins on the day of surgery and continues through postoperative day 2 Seen twice daily patients will be asked about their pain and assessed for sensory function and strength of their shoulder muscle and hand grip
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None